Publication

The first drug-related death associated with xylazine use in the UK and Europe.

Rock, Kirsten L
Lawson, Alexander J
Duffy, Joanne
Mellor, Alice
Treble, Ric
Copeland, Caroline S
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2023-05-22
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
On November 8th, 2022, the United States Food and Drug Administration (FDA) issued a statement alerting healthcare professionals to the increasing prevalence of xylazine in illicit drug overdoses in the country. Xylazine is a veterinary medicine with sedative, analgesic and muscle relaxant properties that is used as a heroin/fentanyl adulterant on the illicit drug market in North America. Here we report the first drug-related death associated with xylazine in the United Kingdom.
Citation
Rock KL, Lawson AJ, Duffy J, Mellor A, Treble R, Copeland CS. The first drug-related death associated with xylazine use in the UK and Europe. J Forensic Leg Med. 2023 Jul;97:102542. doi: 10.1016/j.jflm.2023.102542. Epub 2023 May 22. PMID: 37236142.
Type
Article
Description
Publisher
Embedded videos